Mar 08-10, 2027 | Singapore & Online

World Congress on
Precision Medicine and Genomic Healthcare

PrecisionMed 2027 | HYBRID EDITION

 

The World Congress on Precision Medicine and Genomic Healthcare (Precision Med 2027) is a premier international event dedicated to advancing precision medicine, genomics, and personalized healthcare through scientific innovation, interdisciplinary collaboration, and clinical excellence. Scheduled for March 08–10, 2027, in Singapore, this hybrid congress offers participants the flexibility to attend in person or virtually, bringing together leading researchers, clinicians, geneticists, molecular biologists, bioinformaticians, healthcare professionals, pharmaceutical experts, industry leaders, and policymakers from around the world.

Theme: Unlocking the Potential of Genomics to Transform Precision Healthcare

The conference features an engaging scientific program comprising keynote addresses by internationally renowned experts, plenary lectures, panel discussions, oral and poster presentations, young researcher sessions, workshops, and networking events. These sessions are designed to foster collaboration between academic institutions, healthcare organizations, biotechnology companies, pharmaceutical industries, diagnostic laboratories, and research centers while encouraging the translation of scientific discoveries into real-world clinical applications.

Join us in Singapore or participate online to be part of this transformative global gathering and contribute to advancing the next generation of precision medicine and genomic healthcare.

Conference Dates

March 08-10, 2027

Conference Venue

Village Hotel Changi
1 Netheravon Rd, Singapore 508502

Scientific Sessions

 

Foundations of Precision Medicine and Personalized Healthcare

Precision Medicine and Personalized Healthcare are revolutionizing modern healthcare by replacing generalized treatment approaches with individualized care based on a patient's genetic profile, lifestyle, environmental factors, and clinical history. Advances in genomic medicine, molecular diagnostics, pharmacogenomics, and artificial intelligence enable healthcare providers to deliver more accurate diagnoses, targeted therapies, and preventive interventions. This patient-centered approach improves treatment effectiveness, minimizes adverse drug reactions, and supports better long-term health outcomes across a wide range of medical specialties, including oncology, cardiology, neurology, and rare genetic disorders.

This scientific session will highlight the latest developments in precision medicine, biomarker discovery, personalized therapeutics, and data-driven clinical decision-making. It will provide a platform for researchers, clinicians, geneticists, bioinformaticians, and healthcare innovators to discuss emerging technologies, translational research, and real-world clinical applications. Participants will explore how personalized healthcare is transforming disease prevention, diagnosis, and treatment while addressing the ethical, regulatory, and implementation challenges of integrating precision medicine into routine clinical practice.

Advances in Human Genomics

Human Genomics has become a driving force in modern biomedical research, enabling a deeper understanding of the genetic basis of health and disease. Rapid advancements in genome sequencing, next-generation sequencing (NGS), genome-wide association studies (GWAS), and bioinformatics have transformed the diagnosis, prevention, and treatment of complex disorders. These innovations are improving the identification of disease-causing variants, supporting early detection, and paving the way for personalized therapeutic strategies. Human genomics is now integral to precision medicine, rare disease diagnosis, cancer genomics, reproductive health, and population health research.

This scientific session will explore the latest breakthroughs in human genomics, genomic technologies, functional genomics, and their clinical applications. It will bring together geneticists, clinicians, molecular biologists, bioinformaticians, researchers, and healthcare professionals to discuss emerging discoveries, translational research, and innovative genomic tools. Participants will gain insights into the role of genomics in disease prediction, therapeutic development, and precision healthcare while addressing ethical, legal, and societal challenges associated with genomic data and genetic testing.

AI-Powered Precision Medicine

AI-Powered Precision Medicine is transforming healthcare by combining artificial intelligence, machine learning, and advanced data analytics with genomic, clinical, and imaging data to deliver highly personalized patient care. AI-driven algorithms can identify disease patterns, predict treatment responses, and support early diagnosis with greater speed and accuracy than traditional methods. These technologies are enhancing clinical decision-making, optimizing targeted therapies, improving patient outcomes, and accelerating drug discovery across fields such as oncology, cardiology, neurology, and rare diseases.

This scientific session will showcase the latest innovations in AI-powered precision medicine, focusing on intelligent diagnostics, predictive analytics, precision therapeutics, and digital health solutions. Experts from medicine, data science, bioinformatics, genomics, and healthcare technology will discuss cutting-edge research, real-world clinical applications, and the challenges of integrating AI into routine healthcare. Participants will gain insights into how AI is reshaping personalized medicine while addressing data privacy, algorithm transparency, regulatory frameworks, and ethical considerations for future clinical practice.

Multi-Omics Integration and Systems Biology

Multi-Omics Integration and Systems Biology are transforming biomedical research by combining data from genomics, transcriptomics, proteomics, metabolomics, and epigenomics to provide a comprehensive understanding of biological systems and disease mechanisms. By integrating diverse molecular datasets with advanced computational modeling, bioinformatics, and artificial intelligence, researchers can uncover complex biological networks, identify novel biomarkers, and accelerate the development of precision medicine strategies. These approaches are advancing disease diagnosis, therapeutic target discovery, drug development, and personalized treatment across oncology, neurology, cardiovascular diseases, metabolic disorders, and infectious diseases.

This scientific session will highlight the latest advances in multi-omics technologies, systems biology, computational biology, and translational medicine. It will bring together researchers, clinicians, bioinformaticians, computational biologists, and healthcare innovators to discuss data integration methods, network biology, predictive modeling, and clinical applications of multi-omics research. Participants will gain insights into how integrated molecular profiling is enabling precision diagnostics, personalized therapeutics, and improved patient outcomes while addressing challenges related to big data analytics, interoperability, and clinical implementation.

Single-Cell Sequencing and Spatial Biology

Single-Cell Sequencing and Spatial Biology are revolutionizing biomedical research by enabling scientists to analyze individual cells and their spatial organization within tissues. Unlike conventional bulk sequencing, single-cell sequencing uncovers cellular heterogeneity, gene expression patterns, and molecular interactions at unprecedented resolution. Combined with spatial transcriptomics and advanced imaging technologies, these approaches provide valuable insights into tissue architecture, cell-to-cell communication, disease progression, and therapeutic response. They are driving breakthroughs in precision medicine, cancer research, immunology, neuroscience, developmental biology, and regenerative medicine.

This scientific session will focus on the latest innovations in single-cell genomics, spatial omics technologies, computational biology, and translational medicine. Researchers, clinicians, molecular biologists, and bioinformaticians will discuss emerging sequencing platforms, spatial data integration, biomarker discovery, and clinical applications that enhance disease diagnosis and personalized treatment. The session will also address challenges in data analysis, scalability, and clinical implementation while exploring future opportunities for integrating single-cell and spatial biology into next-generation healthcare.

Precision Oncology and Cancer Genomics

Precision Oncology and Cancer Genomics are transforming cancer care by leveraging genomic profiling, molecular diagnostics, and biomarker-driven therapies to deliver personalized treatment strategies. Advances in next-generation sequencing (NGS), liquid biopsy, and comprehensive tumor profiling enable clinicians to identify genetic mutations, predict therapeutic responses, and select targeted treatments tailored to individual patients. These innovations are improving early cancer detection, enhancing treatment efficacy, reducing adverse effects, and supporting better clinical outcomes across a wide range of solid tumors and hematologic malignancies.

This scientific session will explore the latest developments in precision oncology, cancer genomics, and translational cancer research. It will bring together oncologists, geneticists, molecular biologists, pathologists, bioinformaticians, and pharmaceutical researchers to discuss emerging genomic technologies, targeted therapies, immunogenomics, and AI-driven cancer diagnostics. Participants will gain insights into biomarker discovery, personalized cancer treatment, and clinical implementation while addressing challenges related to genomic data interpretation, resistance mechanisms, and equitable access to precision cancer care.

Liquid Biopsy and Early Cancer Detection

Liquid Biopsy is emerging as a groundbreaking, minimally invasive technology for the early detection of cancer, disease monitoring, and personalized treatment selection. By analyzing circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, cell-free DNA (cfDNA), and other blood-based biomarkers, liquid biopsy enables clinicians to identify genetic alterations without the need for invasive tissue biopsies. This innovative approach supports early diagnosis, real-time monitoring of tumor evolution, detection of minimal residual disease, and assessment of treatment response, significantly improving patient outcomes and advancing precision oncology.

This scientific session will highlight recent advances in liquid biopsy, molecular diagnostics, and cancer biomarker research. Experts in oncology, molecular pathology, genomics, laboratory medicine, and translational research will discuss cutting-edge technologies, clinical validation, AI-assisted biomarker analysis, and emerging applications across multiple cancer types. Participants will explore how liquid biopsy is transforming cancer screening, personalized therapy, and disease surveillance while addressing challenges related to analytical accuracy, regulatory standards, and clinical implementation.

Radiomics, Radiogenomics, and Precision Imaging

Radiomics, Radiogenomics, and Precision Imaging are reshaping modern diagnostics by integrating advanced medical imaging with artificial intelligence, genomic profiling, and quantitative image analysis. Radiomics extracts high-dimensional imaging features from CT, MRI, PET, and ultrasound scans to identify disease characteristics that may not be visible to the human eye. Radiogenomics further links these imaging biomarkers with genetic and molecular profiles, enabling non-invasive disease characterization, improved risk assessment, and personalized treatment planning. These technologies are playing a pivotal role in precision oncology, neurology, cardiology, and other clinical specialties.

This scientific session will explore the latest advances in precision imaging, AI-powered image analysis, radiogenomics, and imaging biomarkers. Researchers, radiologists, oncologists, medical physicists, and bioinformaticians will discuss innovative imaging technologies, machine learning applications, clinical validation, and translational research. Participants will gain insights into how imaging-driven precision medicine is improving disease diagnosis, treatment response prediction, and patient management while addressing challenges in data standardization, interoperability, and clinical adoption.

Scientific Committee

 

Conference Schedule

 

Brochure Download

Reload

Past Conference Information

 

Iris Scientific Group takes great pride in announcing the successful outcome of the World Health Care and Nursing Conference (WHCN 2019) which was held in Valencia, Spain from September 23-25, 2019.

For WHCN 2019 Final Program: Click here

For WHCN 2019 Proceedings: Click Here

For WHCN 2019 Gallery: Click Here

In 2019 we were honored with the presence of renowned session leaders and keynote speakers worldwide. We want to thank the scientific committee for their dedicated participation, intellectual expertise, and their high-quality presentations.

Organizing Committee of WHCN 2019:

  • Pirkko Kouri, Savonia University of Applied Sciences, Finland
  • Penny Daugherty, Northside Hospital Cancer Institute, USA
  • Maria Rosaria Mascolo, University of Genoa, Italy
  • Carol A Conley, Boston Medical Center, USA

The Organizing Committee would like to thank the moderators Angela O'Connor, King Edward Memorial Hospital, Australia, and Carrinna A. Hansen, University of Copenhagen, Denmark for their contribution which ensued in the smooth functioning of the conference.

Iris Scientific Group is prerogative to thank the Organizing Committee Members, Keynote speakers; Chairs on engross the plenary sessions, workshops, and special sessions in an expanded manner to make this conference a privileged.

Nursing Conference 2019 Keynote Speakers:

  • Pirkko Kouri, Savonia University of Applied Sciences Ltd, Finland
  • Liisa Kathleen Ortegon, Houston Methodist Hospital, USA
  • Penny Daugherty, Northside Hospital Cancer Institute, USA

Nursing Conference Speakers:

  • Renee B Bazzelle, USA Navy Nurse Corps, USA
  • Susanne Salmela, Vaasa Central Hospital, Finland
  • Noël Busch-Armendariz, The University of Texas at Austin, USA
  • Margaret Bassett, The University of Texas at Austin, USA
  • Deidi Olaya-Rodriguez, Washington University in St. Louis, USA
  • Donna Rolin, The University of Texas at Austin, USA
  • Shirley Evers-Manly, All Health Care/Imani’s, USA
  • Elvessa Narvasa, Canadian Council of Cardiovascular Nurses, Canada
  • Eugenia Trigoso Arjona, Hospital Universitario y Politécnico LA FE, Spain
  • Sonia Casanova Vivas, Health Public Department, Spain
  • Elena Baixauli Gallego, University of Valencia, Spain
  • Arda Teunissen, Spitex Zürich Limmat, Switzerland
  • Angela O'Connor, King Edward Memorial Hospital, Australia
  • Soy Ramsumeer, Comprehensive T2DM Services and A-Z Diabetes & Wound Care Services, USA
  • Pete Nathans, Comprehensive T2DM Services and A-Z Diabetes & Wound Care Services, USA
  • Carrinna A. Hansen, University of Copenhagen, Denmark
  • Krista L. Nelson, Southern Arkansas University, USA
  • Jana Slobodníková, Alexander Dubcek University of Tren?ín, Slovakia
  • Elaine Clear, St Vincent’s University Hospital, Ireland
  • Farooq Brohi, North Tees & Hartlepool NHS Foundation Trust, UK
  • Revue Eric, Lariboisière Hospital, France
  • Nojoud Alreshidi, University of Hail, Saudi Arabia
  • Nayara Perla Silva, Government of the state of Pernambuco, Brazil
  • Lubinu Francesco, CPS Lugano, Switzerland
  • Tiina Arpola, Savonia University of Applied Sciences, Finland
  • Hanna-Mari Nevala, Savonia University of Applied Sciences, Finland
  • Mona Taylor, Thompson Rivers University, Canada
  • Margaret C. Maimbolwa, University of Zambia, Zambia
  • Zhenhua SANG, Beijing Tsinghua Chang Gung Hospital, China
  • Pei-Shan Lee, Linkou Chang Gung Memorial Hospital, Taiwan
  • Shui-Tao Hu, Chang Gung Memorial Hospital, Taiwan
  • Juan Cai, Beijing Tsinghua Changgung Hospital, China
  • Chuan Yun-Zhang, Beijing Tsinghua Changgung Hospital, China
  • Jantakan Kanjanawetang, Suranaree University of Technology, Thailand
  • Joanna Chyliska, Medical University of Warsaw, Poland

Nursing Conference 2019 Workshops:

  • Workshop on: Interprofessional education and its integration into a nursing curriculum

Cynthia Horton, Cecil College, USA

  • Workshop on: Hospital offers living lab platform to advance nursing

Merita Kaunisto, Kuopio University Hospital, Finland

Hanna-Mari Nevala, Savonia University of Applied Sciences, Finland

Tiina Arpola, Savonia University of Applied Sciences, Finland

Nursing Conference 2019 Poster Presenters:

  • Chantira Chiaranai, Suranaree University of Technology, Thailand
  • Warithorn Prawatwong, Suranaree University of Technology, Thailand
  • Saranya Chularee, Suranaree University of Technology, Thailand
  • Mi-Chun Chou, Chang Gung Memorial Hospital, Taiwan
  • Tzu-Ting Chen, Chang Gung Memorial Hospital, Taiwan
  • Li hua Cheng, Chang Gung Memorial Hospital, Taiwan
  • Pei-Chien Lu, Chang Gung Memorial Hospital, Taiwan
  • Soy Ramsumeer, Comprehensive T2DM Services and A-Z Diabetes & Wound Care Services, USA
  • Pete Nathans, Comprehensive T2DM Services and A-Z Diabetes & Wound Care Services, USA
  • Susan Berry Cann, St Elizabeth’s Medical Center, USA

We congratulate the Best poster award winner Chantira Chiaranai, Suranaree University of Technology, Thailand. We would also like to thank Cynthia Horton, Cecil College, USA who supported us by evaluating the posters.

We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.

We greatly hope to see you again, with added vigor and with your other colleagues in "3rd International Nursing Networking Conference (INNC-2025)" during April 23-25, 2025, at Las Vegas, USA, and in Virtual format.

Iris Scientific Group takes great pride in announcing the successful outcome of the World Catalysis and Chemical Engineering Network Congress (WCCN 2025) which was held in Virtual Mode from April 23-25, 2025.

For WCCN 2025 Final Program: Click Here

In 2025 we were honored with the presence of renowned session leaders and keynote speakers worldwide. We want to thank the scientific committee for their dedicated participation, intellectual expertise, and their high-quality presentations.

Organizing Committee of WCCN 2025:

  • Dai-Yeun Jeong, Director of Asia Climate Change Education Center, South Korea
  • Thomas Webster, Hebei University of Technology, United States
  • Eleonora Aneggi, University of Udine, Italy
  • Maria Jose Lavorante, Institution of Scientific and Technological Research for Defense, Argentina
  • Tokeer Ahmad, Jamia Millia Islamia, India
  • Vasily Lutsyk, Buryat State University, Russia
  • Valery P. Kalinitchenko, Institute of Fertility of Soils of South Russia, Russia

The Organizing Committee would like to thank the moderators Maria Jose Lavorante, Institution of Scientific and Technological Research for Defense, Argentina and Rahul Hajare, Sandip University, India for their contribution which ensued in the smooth functioning of the conference.

 Iris Scientific Group is prerogative to thank the Organizing Committee Members, Keynote speakers; Chairs on engross the plenary sessions, workshops, and special sessions in an expanded manner to make this conference a privileged.

WCCN 2025 Keynote Speakers:

  • Dai-Yeun Jeong, Director of Asia Climate Change Education Center, South Korea
  • Thomas Webster, Hebei University of Technology, United States
  • Eleonora Aneggi, University of Udine, Italy
  • Maria Jose Lavorante, Institution of Scientific and Technological Research for Defense, Argentina
  • Tokeer Ahmad, Jamia Millia Islamia, India
  • Vasily Lutsyk, Buryat State University, Russia
  • Valery P. Kalinitchenko, Institute of Fertility of Soils of South Russia, Russia

WCCN 2025 Plenary Speakers:

  • Alexander G. Ramm, Kansas State University, USA

WCCN 2025 Speakers:

  • Joanna Drzezdzon, University in GdaÅ„sk, Poland
  • Kumar Sachin, Taylors University, Malaysia
  • Rahul Hajare, Sandip University, India
  • Ashanendu Mandal, University of Calcutta, India
  • Omvir Singh, Rajiv Gandhi Institute of Petroleum Technology, India
  • Delia Teresa Sponza, Dokuz Eylul University, Turkey
  • Jose Angel Siles Lopez, University of Córdoba, Spain
  • Osman Adiguzel, Firat University, Turkey
  • Мikhail Kashchenko, Ural Federal University, Russia
  • Luis Isernia, University of Oriente, Venezuela
  • Orlando Elguera, National University of Engineering, Peru
  • Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
  • Ali Yetgin, Cukurova University, Turkey
  • Lazhar Hajji, University of Al Manar Tunis, Tunisia

We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.

We greatly hope to see you again, with added vigor and with your other colleagues in “2nd World Catalysis and Chemical Engineering Network Congress (WCCN 2026)” during April 22-24, 2026. WCCN 2026 will be a hybrid event, offering both in-person and virtual participation options, allowing attendees to engage from anywhere in the world.

Iris Scientific Group takes great pride in announcing the successful outcome of the 3rd International Nursing Networking Conference (INNC 2025) which was held in Virtual Mode from April 23-25, 2025.

For INNC 2025 Final Program: Click Here

In 2025 we were honored with the presence of renowned session leaders and keynote speakers worldwide. We want to thank the scientific committee for their dedicated participation, intellectual expertise, and their high-quality presentations.

Organizing Committee of INNC 2025:

  • Sofica Bistriceanu, Academic Medical Unit - CMI, Romania
  • Bernd Blobel, University of Regensburg, Germany
  • Daryle Wane, Pasco-Hernando State College, United States
  • Petrova Nataliya, Saint Petersburg State I. P. Pavlov Medical University, Russian Federation

The Organizing Committee would like to thank the moderators Sofica Bistriceanu, Academic Medical Unit - CMI, Romania, and Anum Fatima, Chiang Mai University, Thailand for their contribution which ensued in the smooth functioning of the conference.

Iris Scientific Group is prerogative to thank the Organizing Committee Members, Keynote speakers; Chairs on engross the plenary sessions, workshops, and special sessions in an expanded manner to make this conference a privileged.

INNC 2025 Keynote Speakers:

  • Sofica Bistriceanu, Academic Medical Unit - CMI, Romania
  • Bernd Blobel, University of Regensburg, Germany
  • Daryle Wane, Pasco-Hernando State College, United States
  • Petrova Nataliya, Saint Petersburg State I. P. Pavlov Medical University, Russian Federation

INNC 2025 Speakers:

  • Neomie Congello, California State University Channel Islands, United States
  • Saumya Pandey, Indira IVF Hospital, India
  • Liangmei Chen, Xi'an Mental Health Center, China
  • Schaffer Daniela, Klagenfurt Hospital, Austria
  • Franz Porzsolt, Private Research Institute Clinical Economics, Germany
  • Melike Yavas Celik, Gaziantep University, Turkey
  • Kenneth R. Marileise Roberta Antoneli Fonseca, Universidade Estadual de Campinas (UNICAMP), Brazil
  • Juliet Ugbedeojo Shaibu, Global Health Policy Task Force, WFPHA, Switzerland
  • Anum Fatima, Chiang Mai University, Thailand
  • Ayan Chatterjee, Medhavi Skills University, India
  • David John Wortley, UK
  • Humna Baig, Al Rehaab, Pakistan
  • Mohammad Hossein Delshad, Torbat Heydariyeh University of Medical Sciences, Iran, Islamic Republic of
  • Mary Anbarasi Johnson, College of Nursing, India
  • Vanessa Williams Harvey, HippoCLIN, United States
  • Nonye Tochi Aghanya, United States
  • Yousef Ahmed Al shaabi, Sana, a University, Yemen
  • El moubchiri chaimaa, Hassan First University of Settat, Morocco

INNC 2025 Poster Presenters:

  • Ashley N. Frederick, Western Illinois University, United States
  • Dylan Salrin, Children's Hospital Colorado, United States
  • Hanan Morsy Salim Metwally, Zagazig University, Egypt
  • Lt Col Yamuna CB, Army & Delhi University, India

We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.

We greatly hope to see you again, with added vigor and with your other colleagues in “4th International Nursing Networking Conference (INNC 2026)” during April 13-15, 2026. INNC 2026 will be a hybrid event, offering both in-person and virtual participation options, allowing attendees to engage from anywhere in the world.

Iris Scientific Group takes great pride in announcing the successful outcome of the International Cancer Conference (ICC 2025) which was held in Virtual Mode from November 27-29, 2025.

For ICC 2025 Final Program: Click Here

In 2025 we were honored with the presence of renowned session leaders and keynote speakers worldwide. We want to thank the scientific committee for their dedicated participation, intellectual expertise, and their high-quality presentations.

Organizing Committee of ICC 2025:

  • Orestis Ioannidis, Aristotle University of Thessaloniki, Greece
  • Jacques Pouyssegur, University of Nice, France
  • Manmohan Agarwal, Pushpadi Cancer Care Centre, India
  • Kye Young Lee, Konkuk University Medical Center, South Korea
  • Arezou Ghazani, Harvard Medical School, United States
  • Toshiko Kato, Independent researcher, Japan

The Organizing Committee would like to thank the moderators Don Mathew, Pacific Medical College & Hospital, India for his contribution which ensued in the smooth functioning of the conference.

 Iris Scientific Group is prerogative to thank the Organizing Committee Members, Keynote speakers; Chairs on engross the plenary sessions, workshops, and special sessions in an expanded manner to make this conference a privileged.

ICC 2025 Keynote Speakers:

  • Orestis Ioannidis, Aristotle University of Thessaloniki, Greece
  • Jacques Pouyssegur, University of Nice, France
  • Manmohan Agarwal, Pushpadi Cancer Care Centre, India
  • Kye Young Lee, Konkuk University Medical Center, South Korea
  • Arezou Ghazani, Harvard Medical School, United States
  • Toshiko Kato, Independent researcher, Japan
  • Don Mathew, Pacific Medical College & Hospital, India
  • Homer S. Black, Baylor College of Medicine, United States

ICC 2025 Speakers:

  • Jun Bai, Shaanxi Provincial People’s Hosptital, China
  • Michael Firer, Ariel University, Israel
  • Manisha Lakhanpal Sharma, Consultant Emanate Dental Clinic, India
  • Mohite Utkarsha Laxman, MET's League of Colleges Bhujbal, India
  • Saad Sabbar Dahham, University of Technology and Applied Science, Oman
  • Emma Holly, Restore Therapy Ltd, United Kingdom
  • Lorenzo Andreani, Azienda Ospedaliero Universitaria Pisana, Italy
  • Nomeda Juodziukyniene, University of Health Sciences, Lithuania
  • Vladan Radosavljevic, Military Medical Academy, Serbia
  • Nermeen M. ElBakary, Egyptian atomic energy authority, Egypt
  • Ali Mehboob, Genesis Biotech Group LLC, USA
  • Asfar S. Azmi, Wayne State University, United States
  • Nguyen Dinh Song, Cho Ray Hospital, Vietnam

We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.

We greatly hope to see you again, with added vigor and with your other colleagues in “2nd Edition of International Cancer Conference (ICC 2026)” during November 09-11, 2026. ICC 2026 will be a hybrid event, offering both in-person and virtual participation options, allowing attendees to engage from anywhere in the world.

Iris Scientific Group takes great pride in announcing the successful outcome of the Global Conference on Material Science and Nanotechnology (GCMN 2025) which was held in Virtual Mode from April 28-30, 2025.

For GCMN 2025 Final Program: Click Here

In 2025 we were honored with the presence of renowned session leaders and keynote speakers worldwide. We want to thank the scientific committee for their dedicated participation, intellectual expertise, and their high-quality presentations.

Organizing Committee of GCMN 2025:

  • Stanislav Ordin, Russian Academy of Sciences, Russia
  • Vladimir G. Chigrinov, Hong Kong University of Science and Technology, Hong Kong
  • Paulo Cesar De Morais, Catholic University Of Brasilia, Brazil
  • Roya Dastjerdi, Yazd University, Iran

The Organizing Committee would like to thank the moderators Santoshi Misra, St. Ann's College for women, India for her contribution which ensued in the smooth functioning of the conference.

Iris Scientific Group is prerogative to thank the Organizing Committee Members, Keynote speakers; Chairs on engross the plenary sessions, workshops, and special sessions in an expanded manner to make this conference a privileged.

GCMN 2025 Keynote Speakers:

  • Stanislav Ordin, Russian Academy of Sciences, Russia
  • Vladimir G. Chigrinov, Hong Kong University of Science and Technology, Hong Kong
  • Paulo Cesar De Morais, Catholic University Of Brasilia, Brazil
  • Roya Dastjerdi, Yazd University, Iran

GCMN 2025 Plenary Speakers:

  • Alexander G. Ramm, Kansas State University, USA

GCMN 2025 Speakers:

  • Arun Kumar Singh, Guru Ghasidas Vishwavidyalaya, India
  • Subash Chandra Mishra, India
  • Christopher Oluwatobi Adeogun, South China University of Technology, China
  • Naseem Ahmad, Kunsan National University, Korea, Republic of
  • Manojit De, Guru Gobind Singh Educational Society’s Technical Campus, India
  • Shabina Ali, Abdul Wali Khan University Mardan, Pakistan
  • Maryam Motallebi Aghgonbad, Urmia University, Iran, Islamic Republic of
  • Asmaa Reda Abd EL-Salam, Sadat City University, Egypt
  • Santoshi Misra, St. Ann's College for women, India
  • Sameena Bibi, Air University, Pakistan
  • Bilal Ahmad Reshi, Narsimha Reddy Engineering College, India
  • S.V.A.R.Sastry, Harcourt Butler Technical University, India
  • Suresh C Ameta, PAHER University, India
  • Andrey Belousov, Intensive Care Kharkiv National Medical University, Ukraine
  • Olaniyi Awe, Obafemi Awolowo University, Nigeria

GCMN 2025 Poster Presenters:

  • Dariusz Bochenek, University of Silesia in Katowice, Poland
  • Dagmara BrzeziÅ„ska, University of Silesia in Katowice, Poland

We thank all the participants for their magnificent contribution towards the event which facilitated us for the successful accomplishment of this event.

We greatly hope to see you again, with added vigor and with your other colleagues in “2nd Global Conference on Material Science and Nanotechnology (GCMN 2026)” during April 13-15, 2026.

GCMN 2026 will be a hybrid event, offering both in-person and virtual participation options, allowing attendees to engage from anywhere in the world.

Media Partner

Video Reviews & Photo Gallery

 

What Our Clients Say’s